Reply to: Serum zinc and the risk of depression in men: Observations from a 20-Year follow-up study

Biological Psychiatry

Volumn 77, Issue 3, 2015, Pages e13-e14

  Swardfager, Walter ^a   Herrmann, Nathan ^a   Mazereeuw, Graham ^a   Lanctôt, Krista L ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ZINC;

DEPRESSION; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; LETTER; MALE; META ANALYSIS (TOPIC); MINERAL SUPPLEMENTATION; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; ZINC BLOOD LEVEL; BLOOD;

DEPRESSION; HUMANS; ZINC;

EID: 84928209545     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2014.06.006     Document Type: Letter

References (10)

1. Lehto SM, Tolmunen T, Ruusunen A, Voutilainen S, Tuomainen TP, Kauhanen J (2014): Serum zinc and the risk of depression in men: Observations from a 20-year follow-up study. Biol Psychiatry.
2. Swardfager W, Herrmann N, Mazereeuw G, Goldberger K, Harimoto T, Lanctot KL (2013): Zinc in depression: A meta-analysis. Biol Psychiatry 74:872-878.
3. Lehto SM, Ruusunen A, Tolmunen T, Voutilainen S, Tuomainen TP, Kauhanen J (2013): Dietary zinc intake and the risk of depression in middle-aged men: A 20-year prospective follow-up study. J Affect Disord 150:682-685.
4. Vashum KP, McEvoy M, Milton AH, McElduff P, Hure A, Byles J, Attia J (2014): Dietary zinc is associated with a lower incidence of depression: Findings from two Australian cohorts. J Affective Disord. http://dx.doi.org/10.1016/j.jad.2014.05.016.
5. Lai J, Moxey A, Nowak G, Vashum K, Bailey K, McEvoy M (2012): The efficacy of zinc supplementation in depression: Systematic review of randomised controlled trials. J Affect Disord 136: e31-e39.
6. Solati Z, Jazayeri S, Tehrani-Doost M, Mahmoodianfard S, Gohari MR (2014): Zinc monotherapy increases serum brain-derived neurotrophic factor (BDNF) levels and decreases depressive symptoms in overweight or obese subjects: A double-blind, randomized, placebocontrolled trial [published online ahead of print Jan 7]. Nutr Neurosci. http://dx.doi.org/10.1179/1476830513Y.0000000105.
7. Swardfager W, Herrmann N, McIntyre RS, Mazereeuw G, Goldberger K, Cha DS, et al. (2013): Potential roles of zinc in the pathophysiology and treatment of major depressive disorder. Neurosci Biobehav Rev 37:911-929.
8. Siwek M, Szewczyk B, Dudek D, Styczeń K, Sowa-Kućma M, Młyniec K, et al. (2013): Zinc as a marker of affective disorders. Pharmacol Rep 65:1512-1518.
9. Moylan S, Maes M, Wray NR, Berk M (2013): The neuroprogressive nature of major depressive disorder: Pathways to disease evolution and resistance, and therapeutic implications. Mol Psychiatry 18:595-606.
10. Maes M, Vandoolaeghe E, Neels H, Demedts P, Wauters A, Meltzer HY, et al. (1997): Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness. Biol Psychiatry 42:349-358.